Inquiry Basket
Loading ......
In the fields of life science research and biopharmaceuticals, the development of monoclonal antibodies is of utmost importance. However, obtaining a large number of high-quality monoclonal antibodies remains a key challenge in scientific research and clinical applications. The Magic Hybridoma™ Platform, as a groundbreaking technology, offers an efficient solution to this problem and has become the core engine driving the antibody R&D process.
Figure 1. Introduction to Magic Hybridoma™ Platform.
The Magic Hybridoma™ Platform is a cutting-edge technology designed to overcome the limitations of traditional hybridoma methods, enabling the rapid generation of 50-200 high-quality mouse hybridoma clones per fusion. At its core, this platform leverages the proprietary Magic Mouse Adjuvant, a novel immunization adjuvant that enhances immune responses even with trace amounts of immunogen, making it ideal for challenging targets such as native-conformation proteins, diagnostic markers, and therapeutic antibodies.
The Magic Hybridoma™ Platform redefines monoclonal antibody discovery by combining unprecedented efficiency with exceptional antibody quality. Unlike conventional methods that struggle with low yields or weak immune responses, our platform leverages the proprietary magic mouse adjuvant to deliver:
Technical Principles and Innovative Breakthroughs
The Magic Hybridoma™ Platform overcomes the bottlenecks of traditional hybridoma technologies, with its core lying in the innovative application of the proprietary magic mouse adjuvant. This adjuvant enhances immune efficiency through the following mechanisms:
| Indicator | Traditional Hybridoma Technology | Magic Hybridoma™ Platform |
| Hybridoma Clones per Fusion | <20 | 50-200 |
| Immunogen Dosage | Milligram-level | Microgram-level |
| Antibody Affinity (KD Value) | 10⁻⁷-10⁻⁸ M | 10⁻⁹-10⁻¹⁰ M |
| Compatibility with Difficult Antigens | Poor (e.g., GPCRs) | Excellent |
Cancer Immunotherapy
Vaccine Development
Rare Disease Diagnostic Reagents
The development pathway from target identification to functional antibodies extends far beyond basic hybridoma generation-it requires a fully integrated, expert-driven methodology. At Creative Diagnostics, our magic hybridoma™ platform provides a comprehensive, stage-gated workflow engineered to address each technical challenge, synergizing advanced immunization technologies with many years of antibody development expertise. From initial antigen design through production-ready monoclonal clones, we deliver:
Creative Diagnostics regards antigen design and optimization as its core. This process encompasses a series of meticulous and rigorous procedures, aiming to construct antigens that can effectively stimulate the expected immune responses. In addition, our product Magic™ Hybridoma Growth Factor can provide necessary support during the cell culture process in antigen-related experiments. The following services are indispensable components of this critical stage:
Our core technology, the Magic Mouse Adjuvant, serves as the platform's immune-enhancing core. It is designed to target a wide range of antigens, enabling efficient immune responses. For camelid-based antibody development, we offer the Magic™ Camelid Adjuvant. With our expertise in various molecular targets, we are well-positioned to support partnerships focused on developing immunization strategies for challenging medical conditions, especially in the field of rare neurological diseases.
Creative Diagnostics has cutting-edge technologies and rich experience in the field of hybridoma screening and antibody validation. Our platform combines automated high-throughput technologies with deep analytical expertise to identify not just antibody binders—but functionally superior candidates. We offer you with the following services:
Understand client needs regarding immunogen, research goals, and applications, and create a customized service plan.
Evaluate immunogen purity, concentration, and structure; pretreat as needed. Prepare materials, equipment, and reagents.
Perform immunization by combining pre-treated immunogen with magic mouse adjuvant and administering to mice. Conduct cell fusion to generate hybridoma cells, with strict quality control.
Screen products using advanced techniques to find desired substances, like binding-active antibodies. Analyze subtype, affinity, and specificity.
Scale up production of qualified products via in vitro or in vivo methods. Purify, concentrate, and deliver products with test reports and instructions.
Customer Support and Collaboration
Based on the type of antigen and research objectives, we provide customized immunization workflows and screening strategies. A professional team tailors solutions to meet each client's specific needs, ensuring that every project receives an optimized approach.
We offer free training on hybridoma operations and antibody characterization techniques (e.g., SPR/BLI experimental design). Through professional instruction, we help clients enhance their technical capabilities to better apply the platform's technologies in research.
The Magic Mouse Adjuvant has demonstrated excellent performance across a wide range of immunogen types, such as proteins, peptides, small molecules, and conjugates. Nevertheless, due to the inherent complexity and diversity of immunogens, additional optimization of the immunization protocol may be necessary for some extremely specialized or novel immunogens.
Our antibody screening and characterization services cover a comprehensive range of testing projects. During the screening stage, we mainly use enzyme-linked immunosorbent assay (ELISA) to detect antigen binding activity in hybridoma cell culture supernatants. For the positive clones identified, we will conduct more in-depth analysis, including determining the antibody subtype using isotyping kits, measuring affinity through methods such as surface plasmon resonance (SPR) or biolayer interferometry (BLI).
Creative Diagnostics' magic hybridoma™ platform is a highly efficient antibody research and development technology platform based on the innovative immunoadjuvant magic mouse adjuvant. Our platform provides end-to-end services including customized immunization protocol design, hybridoma cell fusion, antibody screening and identification, as well as technical consultation and training. Through standardized and regulated workflows, we ensure the efficiency and reliability of experiments, as well as the accuracy of results. If you are interested in our services, please feel free to contact us for more details and quotation information of related services.
Loading ......
